Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Term Outcome of Complete Pulpotomy Using MTA vs Biodentine in Symptomatic Irreversible Pulpitis - A Randomized Controlled Trial

NCT07483788 is registered in ClinicalTrials.gov with Dow University of Health Sciences as lead sponsor.

NCT NCT07483788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07483788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Term Outcome of Complete Pulpotomy Using MTA vs Biodentine in Symptomatic Irreversible Pulpitis - A Randomized Controlled Trial
Lead sponsor
Dow University of Health Sciences
Phase
Not applicable
Overall status
Recruiting
Start date
November 2, 2024
Completion date
July 31, 2026
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic irreversible pulpitis (sip)